Cephalexin

Product NDC: 0143-9897
Requested package NDC: 0143-9897-05
11-digit product format: 001439897
Labeler code: 0143
Product ID: 0143-9897_05767850-451f-450d-91f1-e1fe9aa63626
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cephalexin
Dosage form: CAPSULE
Route: ORAL
Labeler: Hikma Pharmaceuticals USA Inc.
Application: ANDA065215
Marketing category: ANDA
Marketing start: 2006-02-01
Marketing end: 0000-00-00
Substance: CEPHALEXIN
Active strength: 500 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0143-9897	0143-9897-05	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065215-001	CEPHALEXIN	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL			2006-01-24
A065215-002	CEPHALEXIN	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL			2006-01-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL		2006-01-24	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL		2006-01-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2006-01-24	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-01-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2006-01-24	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-01-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2006-01-24	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-01-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2006-01-24	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-01-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065215-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2006-01-24	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065215-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-01-24	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 48 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065215-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065215-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065215-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065215-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065215-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065215-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065215-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065215-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065215-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065215-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065215-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065215-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065215-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065215-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065215-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A065215-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065215-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A065215-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065215-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A065215-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065215-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A065215-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065215-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A065215-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065215-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A065215-002	AB	1	`ea99ee380514…`
2023-12-20 04:57 UTC	2023-12	A065215-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A065215-002	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065215-001	AB	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065215-002	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065215-001	AB	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065215-002	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065215-001	AB	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065215-002	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065215-001	AB	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065215-002	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065215-001	AB	1	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	A065215-002	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065215-001	AB	1	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	A065215-002	AB	1	`3bdfa0b2c4d7…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dfa3f520-409c-432e-b6d3-9250d468c772	Product name	1	20250401
64bb7f1a-2c2e-4741-8301-dbfeda7239f6	Product name	1	20190628
398aa563-bb78-fe0f-46a8-757c40ef28bf	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0143-9897-01	EA - Each	0143-9897	b7bdc585-14d0-4753-b904-696e0b87c7d8	1	2012-07-24
0143-9897-05	EA - Each	0143-9897	eae69713-8b50-47be-99e8-b945fb1ac537	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP]	6
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [H.J. HARKINS COMPANY, INC.]	3
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [H.J. HARKINS COMPANY, INC.]	3
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
CEPHALEXIN	ACTIVE MOIETY	OBN7UDS42Y	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1
CEPHALEXIN	ACTIVE MOIETY	OBN7UDS42Y	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [MEDVANTX, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [ALTURA PHARMACEUTICALS, INC.]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OBN7UDS42Y	CEPHALEXIN	23325-78-2	CEPHALEXIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309114	cephalexin 500 MG Oral Capsule	PSN	effe46a4-c383-4171-8ab4-2af9de316f08	3
309114	cephalexin 500 MG Oral Capsule	SCD	effe46a4-c383-4171-8ab4-2af9de316f08	3
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	effe46a4-c383-4171-8ab4-2af9de316f08	3
309112	cephalexin 250 MG Oral Capsule	PSN	27f5aa5b-28ca-4154-b37e-18a931bf3398	1
309114	cephalexin 500 MG Oral Capsule	PSN	27f5aa5b-28ca-4154-b37e-18a931bf3398	1
309114	cephalexin 500 MG Oral Capsule	PSN	803cdf4c-77ec-4b9b-bc2d-873eb236f9c7	1
309114	cephalexin 500 MG Oral Capsule	PSN	9ef147ae-fcc5-4fd1-b65c-7a37dae89b91	1
309112	cephalexin 250 MG Oral Capsule	SCD	27f5aa5b-28ca-4154-b37e-18a931bf3398	1
309114	cephalexin 500 MG Oral Capsule	SCD	27f5aa5b-28ca-4154-b37e-18a931bf3398	1
309114	cephalexin 500 MG Oral Capsule	SCD	803cdf4c-77ec-4b9b-bc2d-873eb236f9c7	1
309114	cephalexin 500 MG Oral Capsule	SCD	9ef147ae-fcc5-4fd1-b65c-7a37dae89b91	1
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	27f5aa5b-28ca-4154-b37e-18a931bf3398	1
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	803cdf4c-77ec-4b9b-bc2d-873eb236f9c7	1
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	9ef147ae-fcc5-4fd1-b65c-7a37dae89b91	1
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	27f5aa5b-28ca-4154-b37e-18a931bf3398	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0143-9897-05	00143989705	500 CAPSULE in 1 BOTTLE, PLASTIC (0143-9897-05)	500 capsule	2006-02-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cephalexin	Hikma Pharmaceuticals USA Inc. \| Al Jazeera for Pharmaceuticals Industries	2020-10-30	HUMAN PRESCRIPTION DRUG LABEL	8
CEPHALEXIN CAPSULES, USP	MedVantx, Inc. \| West-ward Pharmaceutical Corp \| Blenheim Pharmacal, Inc.	2012-04-12	HUMAN PRESCRIPTION DRUG LABEL	1
CEPHALEXIN CAPSULES, USP	H.J. Harkins Company, Inc. \| West-ward Pharmaceutical Corp \| Jazeera Pharmaceutical	2011-12-23	HUMAN PRESCRIPTION DRUG LABEL	3
CEPHALEXIN CAPSULES, USP	Blenheim Pharmacal, Inc.	2010-08-26	HUMAN PRESCRIPTION DRUG LABEL	1
CEPHALEXIN CAPSULES, USP	Altura Pharmaceuticals, Inc.	2010-04-28	HUMAN PRESCRIPTION DRUG LABEL	1